Inovio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.186; its P/E ratio is -0.80; Inovio Pharmaceuticals is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 124.67K	$ 9.15M	$ 784.39K	$ 199.07K	$ 839.12K
Gross Profit	-	-	-	-	-
EBIT	$ -54.15M	$ -37.47M	$ -108.18M	$ -76.60M	$ -106.47M
EBITDA	$ -52.80M	$ -36.11M	$ -106.77M	$ -75.22M	$ -104.23M
Net Income Common Stockholders	$ -54.46M	$ -37.78M	$ -108.50M	$ -79.07M	$ -106.95M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 253.00M	$ 281.88M	$ 348.13M	$ 360.39M	$ 401.31M
Total Assets	$ 348.53M	$ 391.97M	$ 459.40M	$ 445.51M	$ 495.94M
Total Debt	$ 32.07M	$ 32.43M	$ 33.31M	$ 33.65M	$ 33.02M
Net Debt	$ -220.92M	$ -249.45M	$ -314.81M	$ -326.75M	$ -368.29M
Total Liabilities	$ 126.17M	$ 125.27M	$ 161.73M	$ 90.43M	$ 96.27M
Stockholders Equity	$ 222.36M	$ 266.70M	$ 297.67M	$ 355.09M	$ 399.67M
Cash Flow	-
Free Cash Flow	$ -36.51M	$ -67.55M	$ -51.25M	$ -61.88M	$ -38.53M
Operating Cash Flow	$ -36.34M	$ -67.47M	$ -50.53M	$ -61.88M	$ -37.89M
Investing Cash Flow	$ 54.00M	$ 44.56M	$ -10.30M	$ 21.33M	$ -6.49M
Financing Cash Flow	$ 6.67M	$ 3.81M	$ 42.94M	$ 28.42M	$ 47.59M

Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Income Statement >

Inovio Pharmaceuticals Debt to Assets

Balance Sheet >

Inovio Pharmaceuticals Cash Flow

Cash Flow >

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing